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ABSTRACT: Electrochemiluminescence (ECL) has increased in
popularity as a result of its inherent advantages, including but not
limited to portability, simplicity of use, and low reagent
consumption. However, its signiﬁcant advantages are often over
shadowed as a result of its limited speciﬁcity. ECL emissions are
intrinsically broad and lack the deﬁnition of other available
analytical techniques. Furthermore, species with similar functional
groups have almost identical electrochemical behavior and thus
typically emit within approximately the same potential region.
Within this contribution we have demonstrate the use of pH
controlled ECL to prove the presence of two individual species
within a mixed sample. Analysis at a single pH would not provide
this information. We have illustrated the potential of this
methodology to quantify scopolamine alongside sister tropane alkaloid atropine, a known ECL interferent. Previously the
two alkaloids could not be distinguished from one another using a single technique which did not involve a separation strategy.
pH controlled ECL is a simple approach to improve the speciﬁcity of a basic [Ru(bpy)3]
2+
ﬁlm based sensor. By exploiting
molecular characteristics, such as pKa, we have been able to ﬁne-tune our methodology to facilitate identiﬁcation of analytes
previously exhibiting indistinguishable ECL emission. Thus, by improving speciﬁcity, while maintaining operational simplicity
and inexpensive design, we have been able to highlight the potential power of ECL for identiﬁcation of structurally similar
compounds. Further improvements of speciﬁcity, such as demonstrated within this contribution, will only further future
applications of ECL sensors across a range of diﬀerent ﬁelds.
The ability to identify compounds with conﬁdence is afundamental concept of analytical chemistry. Often
analysis of samples, regardless of the ﬁeld, requires the
detection of compounds based upon their structural properties.
This can range from impurity analysis in pharmaceuticals to
identiﬁcation of illicit substances within a forensic context. As
analytical chemistry moves toward greater portability, the
requirement to simplify instrumentation, minimize cost, and
decrease reagent consumption is becoming a key driving force
within method development.1−3 Electrochemiluminescence
(ECL) satisﬁes a number of these criteria.4−7 By combining
the advantages of electrochemistry with photoluminescence,
ECL stands out from other analytical techniques. Unlike its
counterparts, ECL produces luminescence without the require-
ment of an external light source, vastly simplifying the
instrumentation required, allowing it to be packaged within
lightweight portable systems.4−8 Furthermore, the recent
advances in both electrochemical (EC) and ECL systems
have demonstrated the ability to negate the need for
potentiostats by utilizing mobile phones to apply the required
voltage alongside the use of their in-built cameras as the
detector, thus producing low cost, portable, and operationally
simple devices.9,10
As the technology to perform ECL progresses, one
signiﬁcant limitation remains. Speciﬁcity has long plagued
both EC and ECL techniques. The principles upon which both
techniques operate suﬀer from a lack of speciﬁcity as a result of
the redox chemistry across functional groups remaining largely
similar.5 One commonly encountered functional group which
suﬀers from this lack of speciﬁcity are amines. A large number
of amine compounds have been shown to be strong ECL
coreactants. However, their redox chemistry and hence
emission mechanisms are largely similar, and thus their signals
are observed across the same potential range.5,11−15 This can
make identiﬁcation of a speciﬁc species problematic and can
limit identiﬁcation to a high level functional group
classiﬁcation. Furthermore, similar species such as tropane
alkaloids, which contain a tertiary nitrogen group within their
tropane ring, are also observed to emit in this region and thus
further complicate class identiﬁcation.16−18 Therefore, it has
been necessary until now to employ separation strategies, such
as chromatography or capillary electrophoresis (CE) prior to
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EC or ECL detection such that analytes which are structurally
similar are identiﬁed via their retention or migration
times.19−22
A number of methodologies have been recently established
to improve the speciﬁcity of EC and ECL techniques. These
largely focus on the addition of a secondary species to modify
the electrode surface. Commonly employed methods include
the addition of biological molecules such as single stranded
apatmers23−25 and antibodies8,26 but can also include non-
biological materials such as Schiﬀ bases,27,28 carbon nano-
tubes,29 ﬂuorescent probes30 and speciﬁcally designed metal
complexes.31,32 Biological species in particular demonstrate a
high degree of selectivity toward the molecule of interest.
These can be speciﬁcally designed to interact with one
particular species. Following this interaction, a “signal oﬀ” or
“signal on” approach is observed. When the target analyte is
present, the ECL probes are either released from the electrode
surface, thus a decrease in ECL is observed or are brought
close to the electrode surface thus facilitating the commence-
ment of electrochemistry, resulting in the increase or
appearance of a signal.23,25 Alternative biological based
approaches investigate the incorporation of the recognition
group into the coreactant species rather than the electrode
surface. This technique showed promise and oﬀered a simpler
methodology than electrode modiﬁcation previously pro-
posed.33
Although the above mention techniques have demonstrated
a high degree of speciﬁcity, making them powerful
modiﬁcation strategies, they are both complex and expensive
to perform. In contrast, we propose within this contribution a
simple strategy to increase ECL speciﬁcity without requiring
the inclusion of additional species to the electrode surface, bar
the necessary luminophore. Despite their almost identical
chemical structure and electrochemical properties, we have
been able to diﬀerentiate between two tropane alkaloids,
atropine sulfate and scopolamine hydrobromide. By eﬀectively
switching oﬀ emission from atropine, while maintaining
scopolamine emission, we have been able to quantify
scopolamine in the presence of atropine. Exploiting the
diﬀerence in pKa values and subsequently adjusting sample
pH accordingly, we have shown that emission from a basic
[Ru(bpy)3]
2+ ECL sensor can be tuned to provide greater
speciﬁcity. Furthermore, unlike the biological or chemical
modiﬁcations, which require expertise to perform, our simple
system could be easily adapted to accommodate a range of
skills levels across a number of ﬁelds, thus further widening its
applications. In addition, by preventing the use of the selective
reagents, we can apply the developed sensor to a wide range of
diﬀerent species without requiring the redesign of electrode
modiﬁcation. By negating the requirement for a separation
strategy prior to detection, we have maintained instrument and
operational simplicity in addition to portability, all of which
will only stand to further encourage the use of basic ECL
sensors. Furthermore, expansion of pH controlled ECL to a
more extensive range of compound classes will only stand to
further enhance the possible applications of this combination
of techniques, thus, illustrating the potential of such a strategy
to the wider analytical community.
■ EXPERIMENTAL SECTION
Materials. Tris (2,2′-bipyridyl)-dichlororuthenium(II) hex-
ahydrate ([Ru(bpy)3]·Cl2·6H2O), atropine sulfate monohy-
drate, (−)-scopolamine hydrobromide trihydrate (Sc-HBr),
lithium perchlorate (LiClO4), and 117 Naﬁon (∼5% mixture
of lower aliphatic alcohols and water) were purchased from
Sigma-Aldrich. Absolute EtOH was purchased from VWR
Chemicals. All chemicals were used as received. All solutions
were prepared in Milli-Q water (18 mΩ cm−1).
Instrumentation. A CH instrument model 760D electro-
chemical analyzer and Hamamatsu H10723-20 photomultiplier
tube (PMT) were used for all electrochemical and photo-
luminescence measurements. GSI Technologies Electrochem-
ical carbon screen printed electrodes (SPE) with a 4 mm
carbon working electrode, carbon counter, and Ag reference
were used throughout. Photoluminescence measurements were
performed in a light tight Faraday cage using a speciﬁcally
designed sensor holder to position the PMT directly above the
working electrode.
Fabrication of [Ru(bpy)3]
2+/Naﬁon ECL Sensor. The
sensor was fabricated following the same procedures previously
reported in Brown et al.18 Brieﬂy, 7 μL of a 1:1 (v/v) of 0.5
mM [Ru(bpy)3]
2+ and 0.2% naﬁon in 50:50 EtOH/H2O was
drop-cast onto the electrode surface and allowed to completely
air-dry in darkness prior to use. Prior to sample measurements,
electrodes were preconditioned by performing three subse-
quent CV over the potential range of interest within the
electrolyte solution to achieve a stable signal.
■ RESULTS AND DISCUSSION
ECL Detection of Atropine and Scopolamine. The
ability of a simple ruthenium ﬁlm-based ECL sensor has been
previously shown to reliably detect tropane alkaloids atropine
sulfate and scopolamine hydrobromide both within ideal and
complex matrixes without the requirement for any sample
preparation.18 One of the major limitations of single
luminophore ECL analysis is the lack of speciﬁcity oﬀered as
a result of the broad spectral response observed. Species with
similar functionalities display similar redox behavior, and as a
result, they often produce emission at similar potentials.5 Small
structural diﬀerences have however been seen to demonstrate
slight diﬀerences in redox potentials. This becomes apparent
when examining atropine and scopolamine. The two tropane
alkaloids possess almost identical chemical structures, as shown
in Figure 1a. However, CV and subsequent ECL analysis of
both species individually have shown that the potential at
which oxidation occurs diﬀers for each analyte. The CVs for
both are shown in Figure S1 with atropine observed at a
slightly earlier potential of ∼0.89 V compared with ∼1.30 V
observed for scopolamine at unmodiﬁed carbon electrodes.
The ECL observed for both via their individual interaction
with the Ru2+/3+ redox couple is observed at ∼0.83 and 0.89 V
for atropine and scopolamine, respectively. This mediated
oxidation process is consistent with reported ECL mechanistic
pathways for alkaloids17,18,34,35 It is believed that these slight
diﬀerences arise due to the inﬂuence of the additional epoxide
group present within scopolamines structure. Quantum
calculations performed on both species have shown that the
EHOMO for atropine (−9.590 eV36) is slightly higher than that
observed for scopolamine (−9.780 eV).36 Furthermore,
Mar̀quez et al.37 also reports that EHOMO for scopolamine
exists at lower energies than other alkaloid species including
cocaine and tropane.37 With the distance between the epoxide
and the nitrogen of the tropane group only 2.47 Å,38 it is
proposed that redistribution of the electron density could
result in an inductive eﬀect toward the positive nitrogen within
the tropane ring system, thus stabilizing the cation. As such the
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HOMO for scopolamine will be observed at a lower energy
than atropine, which has no additional electron donating
groups present and thus requires the application of more
positive potentials to promote electro-oxidation.36−38 A similar
trend has been previously reported for similar species including
amino acids where the presence of diﬀerent functional groups
was seen to inﬂuence the oxidation potentials as a result of the
diﬀerence in EHOMO.
11,39,40 This slight potential diﬀerence is
also observed in the ECL intensity (A.U. arbitrary units) of the
alkaloids, see Figure 1b, with atropine’s λECLmax observed at
∼0.83 V and scopolamine at ∼0.89 V. The low onset of ECL
has previously been observed for atropine18 and can be
attributed to the formation of a radical similar to mechanisms
outlined previously.41,42 Despite the diﬀerent oxidation
potentials of atropine and scopolamine, when a mixed sample
is analyzed, the two individual peaks cannot be identiﬁed, as
shown in Figure 1c. This is not unusual since the broad
spectral response observed as a consequence of ECL emission
does not oﬀer the distinctive peaks observed in other
techniques. Moreover, the oxidative-reduction ECL mecha-
nism which is responsible for their ECL emission is almost
identical, since both compounds contain the same tropane
alkaloid functionality, responsible for this electrochemical
behavior. Furthermore, they also follow the same electrolytic
N-dealkylation degradation pathways, similar to those
observed for other structurally similar amine species.18,34,43−46
As such, the ability to diﬀerentiate between these structurally
similar species in addition to other structurally similar amine
species utilizing single luminophore ECL alone is extremely
challenging.
pH Impact on ECL Intensity. It is well-known that pH
signiﬁcantly inﬂuences the intensity of ECL emission, as a
result of whether the oxidizable form of the analyte is dominate
at a particular pH. As such, the greatest intensities are observed
close to the pKa value of the species.
14,17,18,34,47 pH analysis of
atropine previously18 has shown negligible emission is
observed at acidic pH values, with minimal signal between
pH 5 and 7 observed, before a dramatic increase is seen at pH
8.18 In contrast, pH analysis of scopolamine hydrobromide
revealed that a measurable signal is observed across all pH
values. This includes acidic pH values, with an increase in
signal observed at both pH 6 and pH 8. Despite the almost
identical structure of the two alkaloids, their pKa values are
diﬀerent, with atropine reported at 9.8548 and scopolamine
hydrobromide at 7.6.49 The diﬀerence in pKa and subsequently
the proportion of free base species present at diﬀerent pH
values thus presents the opportunity to exploit this diﬀerence
to facilitate the identiﬁcation of the alkaloids separately within
mixed samples. Scopolamine’s lower pKa and hence lower
basicity compared with atropine means that more of its
nonpronated, and hence oxidizable form, will be present at
lower pH values. In fact the proportion of free base
scopolamine present at a physiological pH of 7.4 is reported
to be 70 times more than atropine under the same
conditions.38 Thus, it is therefore not surprising when directly
comparing the ECL intensity dependence with pH for both
species that there are obvious pH ranges where emission from
one species can be essentially switched oﬀ. In contrast to ECL,
there was no observable impact on the CVs due to pH, see
Figure S3. This is most likely due to the Ru2+/3+ species being
the predominant feature in the CV. The onset of ECL does
correlate with the CV responses. It becomes clear when
examining the ECL intensity dependence with pH for each
species that acidic pH values oﬀer the best compromise
between negating the signal response from atropine and
obtaining the maximum signal from scopolamine, see Figure 2.
As such the optimum pH identiﬁed for the detection of
scopolamine in the presence of atropine was determined to be
pH 6. In contrast, scopolamine is observed to emit a
considerable signal at all pH values where atropine emits.
Although it could be thought that pH 11 would oﬀer a viable
pH to optimize atropine emission and negate scopolamine
emission, we have previously shown that emission at this pH is
due to the catalyzed degradation of atropine under alkaline
conditions, leading to the formation of tropine and tropic
acid.18,50 As such, this degradation prevented us from
quantifying atropine in the presence of scopolamine with an
inability to accurately control the concentration of atropine
still present at this pH. Furthermore, tropine is also found to
produce an ECL response and as such will contribute to the
observed signal. Therefore, the proportion of the signal due to
tropine compared with atropine could not be discerned.18
Analytical Performance. Prior to analysis of mixed
samples, it was necessary to prepared suitable calibration
curves at the chosen pH values. The optimum pH for the
determination of scopolamine in the presence of atropine was
chosen as pH 6. Although there are other pH values which
Figure 1. (a) Structures of tropane alkaloids atropine and scopol-
amine (b) ECL responses of atropine sulfate (green) and scopolamine
hydrobromide (purple) with ruthenium modiﬁed carbon electrodes at
a scan rate of 100 mV s−1 in pH 8 0.1 M LiClO4 electrolyte across 0.5
≤ E ≤ 1.3 V vs Ag at a PMT setting of 0.6 V. (c) ECL response of
mixed atropine sulfate and scopolamine hydrobromide sample in pH
8 LiClO4 with the same parameters used for part b.
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resulted in greater ECL intensities, pH 6 produced the greatest
diﬀerence in ECL response for the two alkaloids meaning it
would be ideally suited to discriminate the presence of
scopolamine over atropine. At other pH values, the
contribution from atropine ECL would not make quantiﬁca-
tion of scopolamine possible. pH 10 was also considered, but
the atropine response was larger than that observed for pH 6
where it was negligible, in addition to pH 10 lying close to
where alkaline degradation of atropine is observed.
Thus, a pH 6 calibration curve was prepared for scopolamine
hydrobromide. The developed [Ru(bpy)3]
2+
ﬁlm SPE sensor
utilized in this study has previously demonstrated satisfactory
analytical performance, including reproducibility of 3.0% and
repeatability of 9.2% and exhibits the same behavior here.18
The limit of detection (LOD) for each calibration was
calculated as 0.418 and 0.440 μM for pH 6 and 8, respectively,
based upon the standard deviation of the y intercept and slope
of the regression line.51 The inﬂuence of scopolamine
hydrobromide concentration on ECL intensity at pH 6 was
investigated across a range of 0.625−250 μM. As analyte
concentration increased the ECL intensity was observed to
linearly increase in proportion with maximum ECL response
between 0.625 and 100 μM with a coeﬃcient R2 value of 0.999,
see the inset of Figure 3a. Above 100 μM, a plateau eﬀect was
observed (see Figure S4) which prevented quantiﬁcation above
this concentration. This plateau eﬀect is not unsurprising and
is a previously reported limitation of ECL.18,52 At higher
analyte concentrations, the consumption of ruthenium(III)
becomes the limiting step, where it is consumed at a rate
quicker than it can be produced. As such, a point is reached
when the ECL intensity will no longer increase as analyte
concentration increases.18,52 To tackle this, the ruthenium
concentration present could be increased within the ﬁlm or a
dilution factor taken into account. However, the concen-
trations of scopolamine and atropine are likely to be
encountered in any “real-world” scenario would be far lower,
with concentrations typically ranging from ∼0.99 to 20 μM in
biological or herbal material samples; therefore, it was not
currently necessary to concentrate on quantiﬁcation of these
higher concentrations.53−56 However, this does pose a sizable
limitation in the current methodology, should it be required for
quantiﬁcation rather than qualiﬁcation of higher concentration
samples, and as such, development to improve the applicable
concentration range is ongoing.
In addition to pH 6, a calibration curve was also prepared at
pH 8, the optimum pH where maximum ECL intensity is
observed for each analyte. The same concentration range as for
pH 6 was investigated, with a linearly proportional response
observed with scopolamine concentration at a maximum ECL
intensity with a coeﬃcient R2 value of 0.995, see Figure 3b,
inset. In contrast to pH 6, at pH 8 the linear range was only
observed between 0.625 and 50 μM, see Figure 3b. Above 50
μM, we began to observe the previously described plateau
eﬀect (refer to Figure S5). At concentrations above 80 μM
scopolamine at pH 8, a decrease in the ECL intensity can be
observed. This may partly be due to the more easily oxidizable
form at this pH undergoing direct oxidation generating the
electro-N-dealkylation speciese (aposcopolamine). The for-
mation of aposcopolamine would result in a drop in
concentration of the ECL coreactant, scopolamine, and
therefore result in a drop in ECL production. This can be
attributed to a far greater proportion of scopolamine being
present in its nonprotonated oxidizable form at this pH. Thus,
ruthenium(III) becomes the limiting reagent at a much lower
total concentration due to a higher proportion of scopolamine
species present, which are able to undergo ECL. As can be seen
in both Figure 3a,b, in addition to ECL intensity increasing
with scopolamine concentration, we also observe a slight shift
in the potential at which the maximum response is observed.
This eﬀect is not unexpected and is consistent with prior
Figure 2. Comparison of ECL intensities with pH for atropine sulfate
(green) and scopolamine hydrobromide (pink), with pH 6 high-
lighted at the optimum pH. Both species were prepared in 0.1 M
LiClO4 at the desired pH. Measurements were collected at a scan rate
of 100 mV s−1 across 0.5 ≤ E ≤ 1.36 V vs Ag at a PMT setting of 0.45
V for atropine sulfate and 0.6 V for scopolamine hydrobromide.
Figure 3. Dependence of ECL intensity with scopolamine hydro-
bromide concentration at (a) pH 6 between 0.625 and 100 μM and
(b) pH 8 between 0.625 and 50 μM. All samples were prepared in the
appropriate pH 0.1 M LiClO4 and measured at a scan rate of 100 mV
s−1 across 0.5 ≤ E ≤ 1.26 V vs Ag at a PMT setting of 0.6 V. Insets
show the trend of maximum ECL intensity against scopolamine
hydrobromide concentration.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.9b04922
Anal. Chem. XXXX, XXX, XXX−XXX
D
literature where a shift is observed at both ruthenium modiﬁed
carbon electrodes and unmodiﬁed graphite electrodes.18,57
This shift can likely be attributed to two eﬀects. As the
concentration of scopolamine is increased and we approach the
concentrations at which ruthenium(III) becomes the limiting
reagent, it becomes more diﬃcult to produce the oxidized
species required to undergo ECL. Moreover, as more
scopolamine is present and undergoes the irreversible ECL
mechanisms, a greater concentration of the byproducts,
scopine and formaldehyde, are produced leading to a shift in
the pH of the sample within the inner Helmholtz plane close to
the electrode surface.18,52,57 However, at pH 6, no signiﬁcant
response from atropine was observed so this would not impact
on the ability to determine the presence of scopolamine. At pH
8, the earlier onset of ECL production would indicate the
presence of atropine. Therefore, it is necessary to have both
results to identify the presence of both alkaloids. Without both
sets of data, an indication of the total alkaloid presence could
be taken but identiﬁcation of the number of alkaloids presence
would not be possible.
Mixed Alkaloid Sample Analysis. To establish whether
the analyte pKa could be exploited to successfully quantify
individual analytes with similar ECL emission mechanisms
within the same sample matrix, the two tropane alkaloids
atropine and scopolamine were used as model compounds in
this proof-of-concept study. Samples containing both alkaloids
were prepared and measured at pH 6, where only scopolamine
emission is expected, pH 8 where both species produce the
greatest ECL intensity, and pH 11 where atropine’s emission
over scopolamine is the greatest. The scopolamine concen-
tration was kept constant in both sets of pH 6 and 8 samples at
50 μM while the atropine sulfate concentration was varied
between 12.5 and 100 μM. For pH 11, concentrations were
reversed, with atropine maintained at 50 μM and scopolamine
varied between 12.5 and 100 μM. Assessment on the ECL
signal intensity due to the presence of atropine was made by
comparing the calculated concentrations of scopolamine
hydrobromide at both pH 6 and 8 to the known
concentrations added. Scopolamine hydrobromide concen-
trations were calculated using the relevant calibration curves
constructed for each pH, see Figure 3a,b, the results of which
are summarized in Table 1. In order to establish whether a
sample contained only scopolamine or if another alkaloid was
present, in this case atropine it is necessary to have the
information for the expected scopolamine signal both at pH 6
and 8 of pure standards. These can then be used as system
standards, in a similar manner as is performed for more
traditional analytical techniques such as HPLC.
The ECL intensity of the pH 8 samples demonstrated a
trend of increasing ECL intensity as the atropine concentration
increased between 12.5 and 50 μM. After this, a decrease in
overall ECL intensity was observed, see Figure 4a. This
decrease is not unexpected and can be attributed to the
ruthenium(III) species becoming the rate limiting reagent. At
pH 8, the free base or nonpronated form of both species will
be the dominate form present. Previously, we have discussed
how 50 μM scopolamine hydrobromide was the maximum
concentration which produced an increasing ECL intensity
with increased concentration. Above 50 μM, the ECL intensity
was no longer dependent on the scopolamine concentration,
and thus 50 μM was the maximum concentration which could
be accurately quantiﬁed. Thus, with scopolamine hydro-
bromide at its maximum quantiﬁable concentration and
atropine sulfate also present at its maximum linearly dependent
concentration of 100 μM, it is thus not unsurprising that a
decrease in ECL intensity is observed. As can be seen in Table
1, the concentration of scopolamine calculated within the pH 8
mixed samples is far greater than the 50 μM present.
Furthermore, examination of the ECL signals, such as those
shown in Figure 4b, demonstrate that the total ECL signal
observed for the mixed alkaloid sample is not the result of
direct addition of the two individual signals for atropine and
scopolamine at this pH. As such, the ECL intensity of
scopolamine hydrobromide cannot be corrected by direct
subtraction of the atropine signal.
In contrast, analysis at pH 6 displayed no increase in total
ECL intensity despite the increasing concentrations of atropine
sulfate present, see Figure 4c. Furthermore, examination of the
signals obtained for 50 μM scopolamine are almost identical to
those observed for the mixed samples, see Figure 4d. Table 1
contains a summary of the scopolamine concentrations
calculated at pH 6 and demonstrates that, despite the presence
of increasing concentrations of atropine, the calculated
scopolamine concentrations remain constant at approximately
50 μM, hence, demonstrating a good accuracy of the
methodology. This promising result demonstrated that by
exploiting the diﬀerence in pKa values, compounds with similar
chemical structures and hence ECL emission mechanisms can
be successfully quantiﬁed within a mixed sample where more
than one species produces an ECL response.
As previously discussed, when samples at pH 11 were
analyzed, the base catalyzed degradation of atropine to the
ECL active degradation product, tropine, prevented quantiﬁ-
cation at this pH. However, with scopolamine producing a
minimal emission intensity of ∼0.34 A.U at pH 11, we are able
to conﬁdently identify the presence of a secondary species; in
this case, atropine is producing the observed signal increase,
refer to Figure 5. Due to the signiﬁcant increase in signal
intensity when atropine is present in addition to scopolamine
at pH 11, we can adequately use pH controlled ECL as a
Table 1. Summary of Atropine Sulfate Concentrations Added and Scopolamine Hydrobromide Concentrations Calculated at
Each pH
pH [atropine] (μM) [scopolamine] added (μM) average calculated [scopolamine] (μM)
6 12.5 50 49.7
6 25 50 50.8
6 50 50 49.3
6 100 50 50.3
8 12.5 50 55.1
8 25 50 67.9
8 50 50 90.2
8 100 50 54.5
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screening protocol to identify the number of species present in
a potential mixed sample. Moreover, although in this current
contribution we have not been able to quantify the multiple
species present, we have established a future application for
chemometric modeling with ECL for the ﬁrst time. By
analyzing samples at pH 6 and subsequently pH 11, one can
identify if both tropane alkaloids are present. Using pH 6 to
negate emission from atropine, the concentration of scopol-
amine can be conﬁdently determined. It is then probable that
knowing the concentration of scopolamine that a calibration
model could be constructed incorporating this known
concentration. Chemometric modeling would then facilitate
the removal of the signal contribution from scopolamine, thus
allowing for the determination of the proportion of the signal
attributed solely to atropine. Using this model, it would then
be possible to determine the concentration of atropine present
in the unknown sample.
■ CONCLUSION
In this work, we have demonstrated for the ﬁrst time the ability
to identify between almost identical chemical structures
through a basic [Ru(bpy)3]
2+ based ECL sensor. Prior to
this, species similar in structure, such as the two alkaloids used
here, could not be diﬀerentiated from one another via ECL
without employing either separation strategies prior to
detection or complex sample preparation to physically separate
out individual components of a mixture.20,58 ECL has long
suﬀered from limited speciﬁcity as a result of its broad
emission spectra leading to indistinctive peaks with groups of
compounds such as amines, all producing emission in the same
Figure 4. (a) Calculated scopolamine hydrobromide (Sc-Hr)
concentrations in the presence of varying concentrations of atropine
sulfate at pH 8. Concentrations calculated based upon maximum ECL
intensity. (b) ECL responses of 50 μM atropine sulfate (pink), 50 μM
scopolamine hydrobromide (purple), and 50 μM atropine sulfate and
Figure 4. continued
scopolamine hydrobromide (yellow) in pH 8 0.1 M LiClO4 as the
electrolyte and measured at a scan rate of 100 mV s−1 across 0.5 ≤ E
≤ 1.36 V vs Ag at a PMT setting of 0.6 V. (c) Calculated scopolamine
hydrobromide concentrations in the presence of varying concen-
trations of atropine sulfate at pH 6. Concentrations calculated based
upon maximum ECL intensity. (d) ECL responses of 50 μM atropine
sulfate (yellow), 50 μM scopolamine hydrobromide (green), and 50
μM atropine sulfate and scopolamine hydrobromide (pink) in pH 6
0.1 M LiClO4 as the electrolyte and measured at a scan rate of 100
mV s−1 across 0.5 ≤ E ≤ 1.36 V vs Ag at a PMT setting of 0.6 V.
Figure 5. ECL intensity with varying concentrations of atropine
sulfate in the presence of 50 μM scopolamine hydrobromide at pH 11
(green). The pink bar represents the ECL intensity observed 50 μM
scopolamine hydrobromide only at pH 11. The blue bar represents
the ECL intensity observed for 50 μM atropine sulfate only at pH 11.
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potential region. Previously, we have reported on the use of the
same basic [Ru(bpy)3]
2+ sensor for the detection of atropine
within herbal plant material and highlighted the inability to
distinguish whether atropine, scopolamine, or both were
responsible for the observed signal.18 By utilizing pH and
exploiting the diﬀerences in pKa, we have been able to develop
a methodology which can be used to qualitatively determine
whether a single species or multiple are responsible for the
observed signal. Furthermore, although we have not been able
to quantify both tropane alkaloids at this time, our pH
controlled ECL strategy can be successfully used for the
quantiﬁcation of scopolamine within a mixed sample
containing various concentrations of atropine. Both tropane
alkaloids as mentioned above have been previously shown to
emit within the same potential region and thus are known to
cause interference for qualifying or quantifying the alkaloids
individually, when they are within the same matrix. Here we
have shown that by closely studying the impact of pH on ECL
emission, we can identify a region where a single species’
emission can in essence be switched oﬀ facilitating the
qualiﬁcation or quantiﬁcation of the remaining emitting
species. Although this is a promising step forward to increase
the speciﬁcity oﬀered by ECL, further development is still
required. Although here we have been able to accurately
quantify scopolamine in the presence of atropine, we could not
successfully perform the reverse. It therefore stands that the
same problem would be encountered for other compound
groups. However, it is hoped that by applying chemometric
modeling to overcome this limitation will allow us to quantify
more species in future. Currently we have solely focused on the
tropane alkaloid family, and thus it is vital that other groups of
structurally similar compounds are also investigated in the
same manner to understand the wider applicability of the pH
controlled ECL. While the initial studies reported within are
promising and despite ECL holding a number of advantages in
comparison to its rivals, its limited speciﬁcity is currently
hindering applications of the technique among the wider
analytical community. As such, alternative methods to further
improve its speciﬁcity are imperative if ECL is to become a
more widely employed technique.
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M. H. P.; Muñoz, R. A. A.; Richter, E. M.; Paixaõ, T. R. L. C.; Coltro,
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